ClinConnect ClinConnect Logo

Main Menu

Search for Trials
Browse by Condition
For Industry
Blog
Contact Us
Dark Mode
Log in Sign up

Clinical Trials for Neuroblastoma

Find clinical trials for neuroblastoma. Discover research opportunities and treatment options in your area.

78 Active Trials Found

Showing 78 trials on this page

Page 1 of 4

Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma

NCT ID: NCT06995872

This clinical trial is testing a new treatment for children and young adults with a type of cancer called neuroblastoma, particularly for those whose cancer has not responded to previous treatments...

Not yet recruiting
Phase: PHASE1 Type: interventional Locations: Bethesda, Maryland, United States

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

NCT ID: NCT06172296

This clinical trial is studying a new treatment approach for children with high-risk neuroblastoma, a type of cancer that affects nerve cells. The researchers want to find out if combining a medici...

Recruiting
Phase: PHASE3 Type: interventional Locations: New Haven, Connecticut, United States, Durham, North Carolina, United States +157 more

N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma

NCT ID: NCT06528496

The N10 clinical trial is looking at a new way to treat children with high-risk neuroblastoma, a type of cancer that can be very challenging to manage. The study aims to see if a treatment called N...

Recruiting
Phase: PHASE2 Type: interventional Locations: New York, New York, United States

Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma

NCT ID: NCT06013618

This clinical trial is studying a new treatment called naxitamab for children with high-risk neuroblastoma, which is a type of cancer that primarily affects young children. The trial is looking at ...

Recruiting
Phase: PHASE2 Type: interventional Locations: Guangzhou, , China, Guangzhou, Guangdong, China

Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome

NCT ID: NCT00588068

**Clinical Trial Summary: Molecular Characterization of Neuroblastic Tumor** This clinical trial aims to better understand neuroblastic tumors, a type of cancer that can affect children. Researche...

Recruiting
Type: observational Locations: New York, New York, United States

Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma

NCT ID: NCT07027748

This clinical trial is studying a new way to give a combination of treatments—including chemotherapy drugs (irinotecan and temozolomide), an immune system booster (sargramostim), and a targeted imm...

Not yet recruiting
Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Boston, Massachusetts, United States

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

NCT ID: NCT06057948

This clinical trial is studying a new treatment approach for children and young adults with high-risk neuroblastoma, a type of cancer that can be very serious and challenging to treat. The research...

Recruiting
Phase: PHASE2 Type: interventional Locations: New York, New York, United States, Montvale, New Jersey, United States +5 more

Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

NCT ID: NCT01005654

This clinical trial is focused on understanding endocrine neoplasms, which are tumors that can occur in glands like the thyroid, parathyroid, adrenal glands, and pancreas. These tumors are becoming...

Recruiting
Type: observational Locations: Bethesda, Maryland, United States, Bethesda, Maryland, United States

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

NCT ID: NCT06395103

This clinical trial, called Substudy 01A, is investigating a new treatment called zilovertamab vedotin for children and young adults with certain types of blood cancers and solid tumors. Specifical...

Recruiting
Phase: PHASE1 Type: interventional Locations: Münster, Nordrhein Westfalen, Germany, São José Do Rio Preto, Sao Paulo, Brazil +60 more

EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

NCT ID: NCT03618381

This clinical trial is looking at a new type of treatment called EGFR806 CAR T Cell Immunotherapy for children and young adults with certain types of solid tumors that have returned or didn’t respo...

Recruiting
Phase: PHASE1 Type: interventional Locations: Seattle, Washington, United States

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

NCT ID: NCT05135975

This clinical trial is exploring the use of a medication called cabozantinib as a maintenance treatment for children and young adults with high-risk solid tumors, specifically neuroblastoma and sar...

Recruiting
Phase: PHASE2 Type: interventional Locations: Washington, District Of Columbia, United States, Columbus, Ohio, United States +4 more

DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations

NCT ID: NCT06988475

The DETERMINE Trial is researching a medication called capmatinib, which is typically used to treat certain types of lung cancer. This study aims to see if capmatinib can also help adults with othe...

Recruiting
Phase: PHASE2 Type: interventional Locations: London, , United Kingdom, Southampton, , United Kingdom +14 more

Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma

NCT ID: NCT06831552

The Resource Intervention to Support Equity (RISE) trial is studying whether adding a new support program, called Pediatric RISE, to the usual care can help children with high-risk neuroblastoma an...

Recruiting
Phase: NA Type: interventional Locations: Boston, Massachusetts, United States

DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers

NCT ID: NCT05770037

The DETERMINE Trial is studying a drug called alectinib, which is already used to treat certain types of lung cancer in adults. Researchers want to see if this medication can also help treat other ...

Recruiting
Phase: PHASE2 Type: interventional Locations: London, , United Kingdom, Leeds, , United Kingdom +26 more

Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biological Studies

NCT ID: NCT01109394

This clinical trial is focused on collecting and storing samples from individuals diagnosed with common childhood cancers, such as leukemia, sarcoma, neuroblastoma, retinoblastoma, and renal cancer...

Recruiting
Type: observational Locations: Bethesda, Maryland, United States, Washington, District Of Columbia, United States +3 more

18F-DOPA II - PET Imaging Optimization

NCT ID: NCT04706910

The 18F-DOPA II clinical trial is studying a type of imaging called PET/CT to see how it can be improved for diagnosing certain health conditions. This trial focuses on patients who are either chil...

Recruiting
Phase: PHASE3 Type: interventional Locations: Edmonton, Alberta, Canada

Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma

NCT ID: NCT03721068

This clinical trial is studying a new treatment for children and young adults with certain types of hard-to-treat cancers, specifically neuroblastoma and osteosarcoma. The treatment combines two po...

Recruiting
Phase: PHASE1 Type: interventional Locations: Chapel Hill, North Carolina, United States, Atlanta, Georgia, United States

A Clinical Trial on Autologous NK Cells Combined With GD2 Monoclonal Antibody in the Treatment of Children With Newly Diagnosed High-risk or Relapsed/Refractory Neuroblastoma

NCT ID: NCT06948994

This clinical trial is exploring a new treatment for children with a type of cancer called neuroblastoma, specifically for those who have either just been diagnosed with high-risk neuroblastoma or ...

Not yet recruiting
Phase: PHASE1 Type: interventional

Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation

NCT ID: NCT06942039

This clinical trial is a pilot study designed to explore the safety and effectiveness of a new treatment approach for young children under 6 years old who are newly diagnosed with high-risk embryon...

Not yet recruiting
Phase: EARLY_PHASE1 Type: interventional

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

NCT ID: NCT04897321

The 3CAR trial is a research study looking at a new type of treatment called immunotherapy for children and young adults (up to 21 years old) with specific types of solid tumors, such as neuroblast...

Recruiting
Phase: PHASE1 Type: interventional Locations: Memphis, Tennessee, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →
Search All Trials Browse All Conditions